| Tag | Content |
|---|
EnhancerAtlas ID | HS109-11940 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr2:29223060-29224200 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr2:29223386-29223404 | TTTTCCTTCCTTCTCTCC | - | 6.42 | | SPI1 | MA0080.4 | chr2:29223488-29223502 | AGAAAGGGGAAGTG | + | 6.22 | | SPIB | MA0081.2 | chr2:29223490-29223502 | AAAGGGGAAGTG | + | 6.07 | | ZNF263 | MA0528.1 | chr2:29223386-29223407 | TTTTCCTTCCTTCTCTCCTCT | - | 6.21 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_11961 | chr2:29222841-29225718 | CD3 | | SE_16451 | chr2:29223150-29224273 | CD4_Naive_Primary_8pool | | SE_20052 | chr2:29222445-29225877 | CD56 | | SE_22467 | chr2:29222505-29226426 | CD8_primiary |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I028999 | chr2 | 29222444 | 29225653 |
|
Enhancer Sequence | GAGATCTCGG TGTGAGGCAC AGTCGCTTGG CAGCTAGGAG GCTCTCAAGA AACGTTTGTT 60
GAGCAGATGA ACAAGGGATT CAACAGCAGG CACTTTATAC TGTCTCTCAT CTGTGTGGTG 120
GACAAGCCAA GTTCAAATCT TAGCCCCGAT ACTCACTGGC TCTGGGGCCT TGGGCAGGTC 180
GGTAACATTT CAGGCCTCGA TTTCCTCCTC TGTGGAATGG GGACACTATT AATAATACTT 240
CTGTGTTACT GTGGGGGTTT AATGAAAACT TGTACACAGA ATTCTCAACA CCTGGCATAT 300
GGGAAGAACT TAATACATTG TTACTATTTT CCTTCCTTCT CTCCTCTTCT GGGTGAATCA 360
TACGGGCTCT TTTCAGCGGA ATGAACTCTT GGGTAACAAG AGCAATAAGA AGTCTTGAGG 420
TCTTAGGAAG AAAGGGGAAG TGCTCTCAAG AGGCACGTGG TTGCTGCCGT CAAGCCTGGG 480
GTTGTGGTTG GCTGTTCTTC CCCTCCCCTG TGCAGACTGC TCCACCTGCT GAGCCTCTCC 540
CTGGAGCCGT GGGGTGTCTC CAGCTCCCGG GGAGCCCAGG ACAATGCCAG GGAGCCTCTG 600
GGAGGAATTG TCCTGGCTGC ACATTATGGA GGCAGAAGGT GGGGTTGGAA TGCCCGAGAA 660
GCTTCCTTAG AACTTCCAGT AGGTACAACT CCTAGAGCTG CCAGACCAAC AACTCTCTCC 720
CTTAGGGGCT TGAAGCCCTT TTCTAGATAT TTCATTTCTT TTTTACAAAG TTCCAGCATA 780
GGGAAAAAAA GAATGGAGTT GTTCTACCTA ATGTTCTGAT GGGCAGTGAC CTATAGACTT 840
ATCAGGCCCC TCAGCAAGCA TGGAGGGCCG GGGATCTCTG GCCCCCGGGC AGTGCTGGGG 900
CTGCTCTGGC CCCTGCATTG AGGCTGAGTT GACTCCTCTG TGCCCTGACC CAGCTGGGGC 960
TCAAGGTGGC CCGGCAAGTG GCACAGTCTC CACTTGACCA CACCCCTTCT TTTCCATCCT 1020
TTCAGCTCCC CACAGGCTAA CCACAACACA ACAGTGCTCC AAGACAGAAC AGAACCAGCA 1080
CCGGAAGCCA GGAGGGGAGC GAGTGTGCAG GAACAGAGAT GATATTTTGA CTTGGCTGGT 1140
|
